• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马德里地区炎症性肠病目前发病率的流行病学研究。

Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid.

机构信息

Service of Digestive, Hospital Universitario Fundación Alcorcón, Madrid, Spain.

出版信息

Rev Esp Enferm Dig. 2009 Nov;101(11):768-72. doi: 10.4321/s1130-01082009001100004.

DOI:10.4321/s1130-01082009001100004
PMID:20001154
Abstract

INTRODUCTION

The incidence of inflammatory bowel disease (IBD) varies widely according to geographical area and has been reported to have increased in the last few years. No data are available on the current incidence of this disease in Madrid (Spain).

AIM

to determine the incidence of inflammatory bowel disease in the area of influence of University Hospital Fundación Alcorcón (Madrid), and to compare our results with those from other Spanish and European series.

PATIENTS AND METHODS

A prospective, population-based study was performed to determine the incidence of IBD in the area of University Hospital Fundación Alcorcón in Madrid between 2003 and 2005. Total population: 213,587 inhabitants (177,490 older than 14 years). Crude rates and age- and sex-specific rates adjusted to the European standard population were calculated. A retrospective study (1998-2003) was also performed.

RESULTS

A total of 69 cases were diagnosed -Crohn s disease (CD): 35, ulcerative colitis (UC): 33, indeterminate colitis: 1- in the prospective period. Crude rates of CD and UC were 7.92 and 7.47 cases/100,000 inhabitants/year, respectively (the population aged 0-14 years). Specific rates were 8.0 (95% CI, 7.03-8.97) and 7.47 (95% CI, 6.5-8.4), respectively. Mean age at diagnosis was 31.02+/- 10.76 and 39.91+/-16.19 years for CD and UC, respectively. Incidence in the retrospective study was 7.13 and 6.22 cases/100,000 inhabitants/year, respectively for CD and UC.

CONCLUSIONS

The incidence of CD and UC in Madrid has increased in the last decades, with rates close to those in northern European countries for CD, higher than those recently published in Spanish prospective studies and similar to those previously described in Spain and southern countries for UC. Rates were higher in the prospective period than in the retrospective one.

摘要

简介

炎症性肠病(IBD)的发病率因地理位置而异,据报道近年来有所增加。目前尚无马德里(西班牙)该疾病发病率的数据。

目的

确定马德里阿尔科孔基金会大学医院(马德里)影响范围内炎症性肠病的发病率,并将我们的结果与其他西班牙和欧洲系列进行比较。

患者和方法

对马德里阿尔科孔基金会大学医院 2003 年至 2005 年期间炎症性肠病的发病率进行了前瞻性、基于人群的研究。总人口:213,587 名居民(177,490 名年龄大于 14 岁)。计算了未经调整的粗发病率和按欧洲标准人口调整的年龄和性别特异性发病率。还进行了回顾性研究(1998-2003 年)。

结果

前瞻性研究期间共诊断出 69 例病例 - 克罗恩病(CD):35 例,溃疡性结肠炎(UC):33 例,不确定结肠炎:1 例。CD 和 UC 的粗发病率分别为 7.92 和 7.47 例/100,000 居民/年(0-14 岁人口)。特定发病率分别为 8.0(95%CI,7.03-8.97)和 7.47(95%CI,6.5-8.4)。CD 和 UC 的平均诊断年龄分别为 31.02+/-10.76 和 39.91+/-16.19 岁。CD 和 UC 的回顾性研究发病率分别为 7.13 和 6.22 例/100,000 居民/年。

结论

马德里 CD 和 UC 的发病率在过去几十年中有所增加,其发病率接近北欧国家的 CD,高于西班牙最近发表的前瞻性研究报告的发病率,与西班牙和南欧国家以前描述的 UC 发病率相似。前瞻性研究期间的发病率高于回顾性研究期间。

相似文献

1
Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid.马德里地区炎症性肠病目前发病率的流行病学研究。
Rev Esp Enferm Dig. 2009 Nov;101(11):768-72. doi: 10.4321/s1130-01082009001100004.
2
[High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study].[西班牙纳瓦拉自治区炎症性肠病的高发病率。一项基于人群的前瞻性研究结果]
Gastroenterol Hepatol. 2008 Mar;31(3):111-6. doi: 10.1157/13116497.
3
[Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA). Spain].[炎症性肠病的发病率和患病率。阿斯图里亚斯5个地区的研究(EIICEA)。西班牙]
An Med Interna. 2003 Jan;20(1):3-9.
4
Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.炎症性肠病诊断时的发病率及表型。EpiCom研究在西班牙的结果。
Gastroenterol Hepatol. 2015 Nov;38(9):534-40. doi: 10.1016/j.gastrohep.2015.03.001. Epub 2015 Apr 15.
5
Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).欧洲炎症性肠病的发病率:南北之间存在差异吗?欧洲炎症性肠病协作研究(EC-IBD)的结果。
Gut. 1996 Nov;39(5):690-7. doi: 10.1136/gut.39.5.690.
6
A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain).一项关于西班牙北部奥维耶多炎症性肠病发病率的基于人群的研究。
Rev Esp Enferm Dig. 2004 May;96(5):296-305. doi: 10.4321/s1130-01082004000500002.
7
Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva.韦尔瓦北部地区慢性炎症性肠病的流行病学
Rev Esp Enferm Dig. 2004 Oct;96(10):687-91; 691-4. doi: 10.4321/s1130-01082004001000003.
8
[Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain].[西班牙阿斯图里亚斯希洪市炎症性肠病的发病率和患病率]
Gastroenterol Hepatol. 2000 Aug-Sep;23(7):322-7.
9
[Epidemiology of chronic inflammatory bowel disease in Gijón, Asturias].[阿斯图里亚斯希洪市慢性炎症性肠病的流行病学]
Gastroenterol Hepatol. 2001 May;24(5):228-35.
10
Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry.西班牙儿科炎症性肠病发病率的增加(1996-2009):SPIRIT 登记研究。
Inflamm Bowel Dis. 2013 Jan;19(1):73-80. doi: 10.1002/ibd.22980.

引用本文的文献

1
Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases.1型发作性睡病合并免疫病理学和自身免疫性疾病患者系列的长期结局
J Clin Med Res. 2022 Aug;14(8):309-314. doi: 10.14740/jocmr4758. Epub 2022 Aug 27.
2
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.EpidemIBD:西班牙炎症性肠病大规模流行病学研究的基本原理与设计
Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019.
3
A Web-Based Telemanagement System for Patients With Complex Inflammatory Bowel Disease: Protocol for a Randomized Controlled Clinical Trial.
一种用于复杂性炎症性肠病患者的基于网络的远程管理系统:一项随机对照临床试验方案
JMIR Res Protoc. 2018 Dec 21;7(12):e190. doi: 10.2196/resprot.9639.
4
Epidemiology and hospital resources use in the treatment of ulcerative colitis at gastroenterology units in Spain (EPICURE study).西班牙胃肠病科溃疡性结肠炎治疗的流行病学及医院资源利用情况(EPICURE研究)
Drugs Context. 2018 Mar 6;7:212505. doi: 10.7573/dic.212505. eCollection 2018.
5
Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?幽门螺杆菌与克罗恩病的流行病学之间存在关联吗?
Dig Dis Sci. 2017 Sep;62(9):2472-2480. doi: 10.1007/s10620-017-4496-z. Epub 2017 Mar 9.
6
Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study.1型发作性睡病与自身免疫性疾病及其他免疫病理学疾病的共病情况:一项病例对照研究。
J Clin Med Res. 2016 Jul;8(7):495-505. doi: 10.14740/jocmr2569w. Epub 2016 May 29.
7
Sex Differences in Experimentally Induced Colitis in Mice: a Role for Estrogens.在小鼠实验性结肠炎中的性别差异:雌激素的作用。
Inflammation. 2015 Oct;38(5):1996-2006. doi: 10.1007/s10753-015-0180-7.
8
Incidence and paris classification of pediatric inflammatory bowel disease.儿童炎症性肠病的发病率及巴黎分类
Gastroenterol Res Pract. 2014;2014:904307. doi: 10.1155/2014/904307. Epub 2014 Mar 20.
9
Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients.沙特阿拉伯的炎症性肠病:一项基于医院的312例患者临床研究。
Ann Saudi Med. 2012 May-Jun;32(3):276-82. doi: 10.5144/0256-4947.2012.276.